XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis - Analyst Ratings

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.57 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate XTLB?

The average price target is $0.00.

XTLB Key Metrics

Key financial metrics for XTLB
MetricValue
Price$2.57
Market Cap$6.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$10.28
52-Week Low$2.12
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

XTLB Analyst Consensus

XTLB analyst coverage data. Average price target: $0.00.

Latest XTLB News

Recent XTLB Insider Trades

  • EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
  • EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
  • EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.

Common questions about XTLB

What do analysts rate XTLB?
The average price target is $0.00.
Does Rallies show XTLB price targets?
Yes. Rallies tracks XTLB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is XTLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.
XTLB

XTLB